4
Changes in Ownership
Opus Genetics, Inc. Filed Acc 0001578563-25-000238
Director acquired 6,927,419 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Foundation Fighting Blindness Retinal Degeneration Fund · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-05-05 | Conversion : show line 1 in the form | +6,927,419 | 9,492,171 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-05-05 | Conversion : show line 2 in the form Series A Non-Voting Convertible Preferred Stock | −6,927.42 | 0 | D |
Loading xslF345X05/primary_doc.xml…